KRYS — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

13.51

Margin Of Safety %

-5

Put/Call OI Ratio

0.78

EPS Next Q Diff

0.4

EPS Last/This Y

0.73

EPS This/Next Y

1.72

Price

326.22

Target Price

373.88

Analyst Recom

1.25

Performance Q

Upside

-46.2%

Beta

0.52

Ticker: KRYS

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-07-13	KRYS	363.23	0.68	0.00	6008
2026-07-14	KRYS	339.43	0.68	0.18	6019
2026-07-15	KRYS	350.59	0.68	0.08	6094
2026-07-16	KRYS	341.48	0.67	0.07	6155
2026-07-17	KRYS	354.8	0.67	0.21	6140
2026-07-20	KRYS	339	0.72	5.47	5670
2026-07-21	KRYS	339.25	0.76	0.36	5847
2026-07-22	KRYS	336.58	0.75	0.17	5956
2026-07-23	KRYS	327.75	0.75	0.03	5968
2026-07-24	KRYS	335.31	0.74	0.00	5996
2026-07-27	KRYS	351.95	0.65	0.04	6498
2026-07-28	KRYS	364.23	0.63	0.12	6670
2026-07-29	KRYS	361.8	0.60	0.04	6961
2026-07-30	KRYS	367.17	0.60	0.06	6962
2026-07-31	KRYS	340	0.59	1.40	7041
2026-08-03	KRYS	312.43	0.63	2.04	7374
2026-08-04	KRYS	324.43	0.75	0.70	8304
2026-08-05	KRYS	325.71	0.75	1.18	8488
2026-08-06	KRYS	322.29	0.77	0.24	8815
2026-08-07	KRYS	326.39	0.78	0.30	8807
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-07-13	KRYS	363.03	48.5	39.8	8.29
2026-07-14	KRYS	339.47	48.5	26.0	8.29
2026-07-15	KRYS	350.30	52.7	49.2	8.42
2026-07-16	KRYS	341.61	52.7	35.7	8.42
2026-07-17	KRYS	354.63	54.3	50.6	8.45
2026-07-20	KRYS	339.24	54.3	31.1	8.45
2026-07-21	KRYS	339.24	54.3	41.4	8.45
2026-07-22	KRYS	336.76	51.7	39.7	8.38
2026-07-23	KRYS	327.77	51.7	35.4	8.38
2026-07-24	KRYS	335.28	48.4	47.3	8.21
2026-07-27	KRYS	351.80	48.4	53.4	8.21
2026-07-28	KRYS	363.70	48.4	49.5	8.21
2026-07-29	KRYS	363.53	48.4	41.1	8.21
2026-07-30	KRYS	367.14	48.4	44.0	8.21
2026-07-31	KRYS	341.05	48.4	24.8	8.21
2026-08-03	KRYS	312.95	48.4	21.8	8.21
2026-08-04	KRYS	312.95	48.4	21.8	8.21
2026-08-05	KRYS	325.56	-18.7	23.1	8.21
2026-08-06	KRYS	322.96	-18.7	20.6	8.21
2026-08-07	KRYS	326.22	-31.8	31.5	7.81
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

19 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-07-13	KRYS	-5.27	-1.05	13.64
2026-07-14	KRYS	-5.27	-1.05	13.64
2026-07-15	KRYS	-5.27	-1.05	13.64
2026-07-16	KRYS	-5.27	-1.05	13.64
2026-07-17	KRYS	-5.27	-1.05	13.64
2026-07-20	KRYS	-5.27	-0.97	13.64
2026-07-21	KRYS	-5.27	-0.97	13.64
2026-07-22	KRYS	-5.27	-0.97	13.64
2026-07-23	KRYS	-5.27	-0.97	13.64
2026-07-24	KRYS	-5.27	-0.97	13.64
2026-07-27	KRYS	-5.27	-0.99	13.56
2026-07-28	KRYS	-5.27	-0.99	13.56
2026-07-29	KRYS	-5.27	-0.99	13.56
2026-07-30	KRYS	-5.27	-0.99	13.56
2026-07-31	KRYS	-5.27	-0.99	13.56
2026-08-03	KRYS	-5.27	-0.48	13.56
2026-08-04	KRYS	-5.27	-0.48	13.56
2026-08-06	KRYS	-5.25	-0.48	13.56
2026-08-07	KRYS	-5.25	-0.48	13.51
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

19 items 1 of 1

Last Quarter Act. EPS

1.79

Avg. EPS Est. Current Quarter

1.81

Avg. EPS Est. Next Quarter

2.19

Insider Transactions

-5.25

Institutional Transactions

-0.48

Beta

0.52

Average Sales Estimate Current Quarter

129

Average Sales Estimate Next Quarter

137

Fair Value

309.14

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

14.7

Max Drawdown 5-Year %

-44.5

Target Price

373.88

P/E

40.91

Forward P/E

36.07

PEG

1.51

P/S

21.94

P/B

7.11

P/Free Cash Flow

37.48

EPS

7.98

Average EPS Est. Cur. Y

7.81

EPS Next Y. (Est.)

9.53

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

54.82

Relative Volume

0.37

Return on Equity vs Sector %

-9.6

Return on Equity vs Industry %

6.5

EPS 1 7Days Diff

-0.4

EPS 1 30Days Diff

-0.48

EBIT Estimation

31.5

◆ KRYS Healthcare

$326.45

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

6/20

Pullback

19/25

Volume

8/15

Valuation

10/20

TP/AR

4/10

Options

4/10

RSI

Range 1M

33.7%

Sup Dist

2.2%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

11/25

Growth

10/30

Estimates

5/20

Inst/Vol

0/15

Options

8/10

EPS Yr

52W%

77.2%

💎

Long-Term Value

Quality companies, undervalued

WEAK

🔴 SELL -16.6% upside

Quality

23/30

Valuation

1/30

Growth

5/25

Stability

7/10

LT Trend

0/5

Upside

-16.6%

Quality

MoS

-5%

KRYS — P/E HistoricalBiotechnology

Krystal Biotech, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 295

Krystal Biotech, Inc., a commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States. The company commercializes VYJUVEK (beremagene geperpavec-svdt, or B-VEC) for the treatment of dystrophic epidermolysis bullosa (DEB). It also develops KB803 for ocular complications of dystrophic epidermolysis bullosa; KB801 for neurotrophic keratitis; KB407, which is in Phase 1 clinical trials for treating cystic fibrosis; KB111 for Hailey-Hailey disease; KB707 for solid tumors; KB304 for dynamic wrinkles; KB707 that is in Phase 1/2 clinical trials for the treatment of anti-PD-1 relapsed/refractory; KB408, which is in Phase 1 clinical trials for treating Alpha-1 antitrypsin deficiency; and KB301 that is in Phase 2 clinical trials for treating aesthetic skin conditions, as well as in open label study with ophthalmic B-VEC for treating for ocular complications of deb. Krystal Biotech, Inc. was founded in 2016 and is headquartered in Pittsburgh, Pennsylvania.

KRYS

Latest News

—

Caricamento notizie per KRYS…

stock quote shares KRYS – Krystal Biotech, Inc. Stock Price stock today

news today KRYS – Krystal Biotech, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch KRYS – Krystal Biotech, Inc. yahoo finance google finance

stock history KRYS – Krystal Biotech, Inc. invest stock market

stock prices KRYS premarket after hours

ticker KRYS fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: KRYS

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y